Top Markets
Coin of the day
XORTX Therapeutics Inc. XORTX Therapeutics Inc.

XORTX Therapeutics Inc.

XRTX
Rankning i aktier #39284
Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm... Based in Vancouver, Canada, XORTX Therapeutics Inc. is a biopharmaceutical firm dedicated to discovering and bringing to market treatments for a variety of conditions, including progressive kidney disorders, diabetes, insulin resistance, metabolic syndrome, and infections. The company's pipeline includes XRx-008, a late-stage clinical program addressing autosomal dominant polycystic kidney disease; XRx-101, an agent designed to reduce uric acid levels in COVID-19 patients to prevent acute kidney injury and its associated health issues; and XRx-221, a series of xanthine oxidase inhibitor candidates aimed at treating diabetic nephropathy. Furthermore, XORTX Therapeutics collaborates with the Icahn School of Medicine to research the occurrence of acute kidney injury and elevated uric acid in patients hospitalized with COVID-19.
Aktiekurs
$2.06
Senast synkroniserad: 2026-08-11
Marknadsvärde
$572.30K
Förändring (1 dag)
0.00%
Förändring (1 år)
-90.38%
Land
CA
Handel XORTX Therapeutics Inc. (XRTX)

Kategori

Aktiekurshistorik för XORTX Therapeutics Inc. (XRTX)
Högsta slutkurs: $2.06 den 2026-08-01

Lägsta slutkurs: $173.60 den 2015-10-01
Aktiekurshistorik för XORTX Therapeutics Inc. från 2015 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -27.44%
2025 -48.32%
2024 -50.05%
2023 -69.00%
2022 -58.91%
2021 105.10%
2020 -34.17%
2019 8.63%
2018 152.77%
2017 -20.67%
2016 22.14%
2015 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$517.18 32.51%
US
$857.76 31.47%
NL
$734.30 7.51%
CH
$1.07K -6.40%
KR
$258.11 14.02%
BE